Capital CS Group, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 249 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
Capital CS Group, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$146,509
-66.3%
17,5250.0%0.17%
-60.0%
Q2 2023$435,321
+65.2%
17,5250.0%0.43%
+73.9%
Q1 2023$263,576
+27.1%
17,5250.0%0.25%
+8.7%
Q4 2022$207,321
+99.3%
17,5250.0%0.23%
+104.5%
Q3 2022$104,000
+40.5%
17,5250.0%0.11%
+45.5%
Q2 2022$74,000
-55.7%
17,5250.0%0.08%
-46.9%
Q1 2022$167,000
-60.5%
17,525
-21.1%
0.14%
-56.3%
Q4 2021$423,000
-34.7%
22,2250.0%0.33%
-44.8%
Q3 2021$648,00022,2250.60%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders